FinancialPress releases

Year-end Report (Q4) July 2023 – June 2024

By August 28, 2024 No Comments

 

 

Related Posts

Press releases

Immunterapi som behandling av återkommande urinvägsinfektioner – nu tre framgångsrika Fas II-studier i Hamlet BioPharma

Hamlet Biopharma
Hamlet BiopharmaOctober 8, 2024
Press releases

Hamlet BioPharmas digitala investerarmöte tidigareläggs till den 9 oktober kl. 12:00 CET

Hamlet Biopharma
Hamlet BiopharmaOctober 1, 2024
Press releases

Positive Phase II study shows similar clinical outcomes of immunotherapy and antibiotic treatment for recurrent acute cystitis, potentially reducing the need for antibiotics

Hamlet Biopharma
Hamlet BiopharmaSeptember 26, 2024
Hamlet Biopharma

Author Hamlet Biopharma

More posts by Hamlet Biopharma

Hamlet Pharma AB

BMC D10
Klinikgatan 32
SE-222 42 Lund, Sweden
+46 40 12 25 00
info@hamletpharma.com

Swedish